BrownE.A.Peritonitis: limiting the damage.Nephrol Dial Transplant2005; 20: 1539–41.
2.
AroeiraL.S., AguileraA., Sanchez-TomeroJ.A., BajoM.A., del PesoG., Jimenez-HeffernanJ.A.Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.J Am Soc Nephrol2007; 18: 2004–13.
3.
LichtensteinA.V., MelkonyanH.S., TomeiL.D., UmanskyS.R.Circulating nucleic acids and apoptosis.Ann N Y Acad Sci2001; 945: 239–49.
4.
JungK., FleischhackerM., RabienA.Cell-free DNA in the blood as a solid tumor biomarker—a critical appraisal of the literature.Clin Chim Acta2010; 411: 1611–24.
5.
DwivediD.J., ToltlL.J., SwystunL.L., PogueJ., LiawK.L., WeitzJ.I.Prognostic utility and characterization of cell-free DNA in patients with severe sepsis.Crit Care2012; 16: R151.
6.
PajekJ., KvederR., GucekA., SkoberneA., BrenA., BucarM.Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions.Ther Apher Dial2010; 14: 20–6.
7.
KorabecnaM., OpatrnaS., WirthJ., RulcovaK., EiseltJ., SefrnaF.Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease.Ann N Y Acad Sci2008; 1137: 296–301.
8.
MoreiraV.G., PrietoB., RodriguezJ.S., AlvarezF.V.Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients.Ann Clin Biochem2010; 47: 253–8.
